# FDA Inspection 683244 - Huzhou Zhanwang Pharmaceutical Co., Ltd. - September 16, 2010

Source: https://www.keypedia.com/records/fda_inspections/huzhou-zhanwang-pharmaceutical-co-ltd/12e705e8-2c21-43d8-9667-e19894cceeb9
Source feed: FDA_Inspections

> FDA Inspection 683244 for Huzhou Zhanwang Pharmaceutical Co., Ltd. on September 16, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 683244
- Company Name: Huzhou Zhanwang Pharmaceutical Co., Ltd.
- Inspection Date: 2010-09-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1237589 - 2024-03-29](https://www.keypedia.com/records/fda_inspections/huzhou-zhanwang-pharmaceutical-co-ltd/5587637b-649c-4642-b8b3-ef1a785ddaf9)
- [FDA Inspection 966455 - 2016-04-08](https://www.keypedia.com/records/fda_inspections/huzhou-zhanwang-pharmaceutical-co-ltd/ac2fe296-fc52-463c-b74b-3dfb487b5a27)
- [FDA Inspection 850476 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/huzhou-zhanwang-pharmaceutical-co-ltd/5ed76107-e793-40c4-8212-148d6eef5ee0)

Company: https://www.keypedia.com/companies/huzhou-zhanwang-pharmaceutical-co-ltd/d4cf8da8-dece-46c3-bbc9-c12134a94b73

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c